This is a review of the literature as regards the indications for blood transfusion in SCD, complications associated with these transfusions and how to reduce these complications in SCD.The objectives of blood transfusion in SCD include the correction of anaemia and the reduction of the circulating Haemoglobin S level to less than 30%.Thus the indications include prophylaxis for the prevention of stroke especially in childhood.The use of exchange blood transfusion is highly advocated inorder to reduce the level of Haemoglobin S to less than 30%. Conditions such as acute chest syndrome and acute exacerbation of severe anaemia in SCD with hepatic and splenic sequestration also benefit from simple transfusion. Elective surgical conditions; apl...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
Sickle cell disease is a genetic disorder characterized by the presence of hemoglobin S. This hemogl...
Blood transfusions are sometimes required, most usually to treat severe anaemia, in patients with si...
Graham R Serjeant Sickle Cell Trust (Jamaica), Kingston, Jamaica Abstract: Homozygous sickle cell (S...
Red cell transfusion has an important role in the management of sickle cell disease (SCD) in both em...
Background. Blood transfusion is an essential component in the care of patients with sickle cell dis...
Blood transfusion in patients with sickle cell disease (SCD) is limited by the development of alloan...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due ...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
Sickle cell disease is a genetic disorder characterized by the presence of hemoglobin S. This hemogl...
Blood transfusions are sometimes required, most usually to treat severe anaemia, in patients with si...
Graham R Serjeant Sickle Cell Trust (Jamaica), Kingston, Jamaica Abstract: Homozygous sickle cell (S...
Red cell transfusion has an important role in the management of sickle cell disease (SCD) in both em...
Background. Blood transfusion is an essential component in the care of patients with sickle cell dis...
Blood transfusion in patients with sickle cell disease (SCD) is limited by the development of alloan...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due ...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
Delayed hemolytic transfusion reactions (DHTR) are potentially life-threatening complications observ...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...